Steven Halper analyst

Currently out of the existing stock ratings of Steven Halper, 301 are a BUY (78.8%), 80 are a HOLD (20.94%), 1 are a SELL (0.26%).

Steven Halper

Work Performance Price Targets & Ratings Chart

Analyst Steven Halper, carries an average stock price target met ratio of 62.39% that have a potential upside of 25.9% achieved within 243 days. Previously, Steven Halper worked at CANTOR FITZGERALD, B. RILEY.

Steven Halper’s has documented 746 price targets and ratings displayed on 47 stocks. The coverage was on Healthcare, Financial Services, Technology, Industrials, Consumer Cyclical sectors.

Most recent stock forecast was given on TRHC, Tabula Rasa HealthCare at 05-Nov-2021.

Wall Street Analyst Steven Halper

Analyst best performing recommendations are on PHR (PHREESIA).
The best stock recommendation documented was for PHR (PHREESIA) at 12/9/2020. The price target of $55 was fulfilled within 1 day with a profit of $2.39 (4.54%) receiving and performance score of 45.43.

Average potential price target upside

AIH Aesthetic Medical Intl Holding Ltd ANTM Anthem ATHN athenahealth CERN Cerner Corp CI Cigna Corp CNC Centene Corp CPSI Computer Programs and Systems CSLT Castlight Health CVS CVS Health Corp EHTH eHealth EVH Evolent Health HIIQ Benefytt Technologies HMSY HMS Holdings Corp HQY HealthEquity HSTM HealthStream HUM Humana MDRX Allscripts Healthcare Solutions NNOX Nano X Imaging Ltd NXGN Nextgen Healthcare OMCL Omnicell PHR Phreesia RCM R1 RCM TDOC Teladoc TVTY Tivity Health UNH UnitedHealth Group VCRA Vocera Communications ABC AmerisourceBergen WCG WellCare Health Plans AMWL American Well Corp CHNG Change Healthcare ELV Elevance Health TRHC Tabula Rasa HealthCare BNFT Benefitfocus HCAT Health Catalyst NYXH Nyxoah WBA Walgreens Boots Alliance OSH Oak Street Health SLQT Selectquote BN Brookfield Corp CPS Cooper Stnd HII Huntington Ingalls Industries MCK McKesson MTBC CareCloud RC Ready Capital Corp ROOT Root TV Grupo Televisa SAB ADR VC Visteon Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

5 years 2 months 21 days ago
(24-Jun-2021)

1/2 (50%)

$2.89 (47.30%)

241

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?